Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if administration of nonsteroidal anti-inflammatory drugs (NSAID) and/or aspirin is effective as chemoprevention for colorectal adenomas and carcinomas in patients with previous colorectal adenomas and/or those who have genetic predispositions, compared to currently available other agents or no intervention and to assess adverse effects associated with the intervention. The following hypotheses will be tested: 1. NSAID and/or aspirin is better than no intervention 2. NSAID and/or aspirin is better than a placebo/sham intervention; 3. Aspirin with combination of resistant starch is better than no intervention; 4. One type of NSAID is better than another type; 5. Increased dose of NSAID and/or aspirin is better than another dose.

Cite

CITATION STYLE

APA

Latchford, A. R., Maeda, Y., & Clark, S. K. (2013). Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition. Cochrane Database of Systematic Reviews, 2013(1). https://doi.org/10.1002/14651858.CD010291

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free